Drug Shortage Report for APO-FLUOXETINE

Last updated on 2023-03-02 History
Report ID 173815
Drug Identification Number 02216361
Brand name APO-FLUOXETINE
Common or Proper name FLUOXETINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) FLUOXETINE
Strength(s) 20MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL and 500 BTL
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2022-11-01
Estimated end date 2023-03-03
Actual end date 2023-03-01
Shortage status Resolved
Updated date 2023-03-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2023-03-02 French Compare
v9 2023-03-02 English Compare
v8 2023-02-09 French Compare
v7 2023-02-09 English Compare
v6 2023-01-20 French Compare
v5 2023-01-20 English Compare
v4 2023-01-13 French Compare
v3 2023-01-13 English Compare
v2 2022-11-04 French Compare
v1 2022-11-04 English Compare

Showing 1 to 10 of 10